AbbVie Inc (ABBV) is trading at $264.52 down 0.17% over the past 24 hours. Its Galaxy Score is 52.8, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 282.8K engagements and 319 posts with 46% positive social sentiment.
AI summary: AbbVie Inc. is a US-listed large-cap pharmaceutical company trading on NYSE under ticker ABBV, built on immunology blockbusters Rinvoq, Skyrizi, and Humira. The +6.24% weekly rally to $265 is being driven by the WCLC 90% ORR lung cancer data win, expanding Rinvoq indications, and analyst upgrades led by Piper Sandler's $303 target, amplified by sector rotation into healthcare, while the VP's $8.18M insider sale and DCF models flagging shares 53% above fair value act as the primary brakes on the move.